Unity of invention and double patenting law and practice in Canada can create challenges for patent applicants. For example, ...

As courts grapple with AI-related IP disputes and regulatory bodies refine their approaches, we must navigate complex ...

This post is part of MoFo’s 2025 Intersection of AI and Life Sciences blog series. In this blog series, we explore how ...

AI models are not only generating valuable insights but also developing proprietary processes, algorithms and datasets that hold immense competitive value. Ensuring the confidentiality of these trade ...

DatChat’s intellectual property provides early and first mover advantages in developing and marketing advanced technology that secures rights to privacy, protection and free speech for social media ...

Milestone's NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Open Invention Network (OIN), the only institution focused on mitigating patent risk in open source software, announced today that more than 4,000 organizations have joined its community and granted ...

Sarfaraz K. Niazi, PhD, gives his opinion on how the recent IQVIA report “Assessing the Biosimilar Void in the US” could be ...